GLUT1 antibody and other transporter antibodies: getting a membrane protein onto the blot
Transporters and multipass receptors are the targets most likely to make a good antibody look dead. They aggregate when boiled, need a detergent that solubilises without destroying the epitope, and are frequently glycosylated enough to run as a smear rather than a band. None of that is the antibody's fault, and all of it is predictable. This page covers the preparation each demands.
- the denaturation range that keeps a multipass protein soluble
- 37-70 C
- the authentication guidance a funded study is expected to follow
- NIH rigor
- the containment human cell lines in the experiment are handled at
- BSL-2
Figures in this panel are the validation and labelling rules a research antibody is bought and used under, named from the guidance itself and linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a reagent price index it has not measured.
- 4 vendor service pages verifiedevery figure matched verbatim to the vendor's page
- Quoted and dated, never estimatedlast verification pass 2026-08-24
- 1 service classes coveredeach with measured search demand behind it
Preparing the sample for a membrane target
- Do not boil a multipass membrane protein. Heating in sample buffer aggregates multipass proteins, and the aggregate stays in the well. Incubating at thirty seven or seventy degrees instead is the single change that rescues most apparently failed transporter blots, and it should be the first thing tried.
- Choose the detergent for solubility and for the epitope. A detergent that extracts the protein may denature the epitope, and a gentle one may leave the target in the pellet. Test two or three on a known positive lysate and look at both the pellet and the supernatant before concluding anything.
- Expect glycosylation to broaden the band. Heavily glycosylated transporters run as a smear well above the predicted mass. Enzymatic deglycosylation collapses it and confirms identity, and it is the fastest way to show that a smear is your protein rather than background.
- Use a genetic negative, and an overexpression positive. For a membrane protein at native abundance, a knockout or knockdown lysate is the control that settles specificity. An overexpression lysate as a positive tells you the antibody can see the protein at all, which is worth knowing before hunting for it at endogenous level.
- Check whether the epitope is intracellular or extracellular. For surface staining of intact cells the epitope must be on an extracellular loop, which for a multipass transporter is a short and awkward region. Antibodies against intracellular loops are common and will not stain an intact cell whatever the protocol.
Membrane preparation rather than whole lysate
Enriching membranes before electrophoresis raises the target relative to abundant soluble protein and makes a low expressed transporter visible. It is a centrifugation step and it frequently makes more difference than any change of antibody.
Keep the whole lysate lane alongside the membrane fraction. Showing the target enriched where it should be is itself a specificity argument.
Immunohistochemistry on transporters
Membrane staining should look like a membrane: a rim around the cell or a polarised face, not a diffuse cytoplasmic haze. A diffuse pattern for a transporter is a warning sign regardless of intensity.
Retrieval conditions matter and differ between these targets, so test two buffers on a known positive tissue. A transporter with a strongly polarised distribution also gives you a built-in internal control: the wrong face is wrong.
Quantifying transporter expression
Blot signal is not proportional to protein over a wide range, so a claim about a fold change needs a dilution series showing linearity in the range measured. For membrane proteins this is skipped more often than for soluble ones.
Where absolute levels matter, a targeted mass spectrometry method with a labelled standard is the honest measurement, and an antibody-based one is a screen.
An MRP1 antibody or PGP antibody: efflux transporters are hard twice over
Efflux transporters are large, heavily glycosylated, multi-pass proteins with substantial family similarity, which makes antibodies against them among the most difficult in the catalogue. Apparent molecular weight moves with glycosylation, so a band at the predicted size may be the wrong protein and a band at the wrong size may be the right one.
Validate against a cell line known to express the transporter and one known not to, and treat a functional assay as the real evidence wherever the claim concerns activity. A stain rarely distinguishes an expressed but inactive transporter from a working one, and in drug-handling studies that distinction is the whole point.
An LDLR antibody or TFR1 antibody for targeting rather than phenotyping
Some receptors in this group are bought less to describe a cell than to decide whether a targeted agent will bind it. There the question is receptor density and accessibility on intact cells, which a denatured blot cannot answer and a surface stain on live cells can.
Choose a reagent whose epitope is extracellular, confirm it stains without permeabilisation, and quantify against beads of known binding capacity where the number matters. An intracellular-epitope reagent will report total protein and say nothing about what a targeting agent can reach.
An orai1 antibody and the channel that needs its partner
ORAI1 forms the calcium release activated channel only with STIM1, so an orai1 antibody is read beside that partner and the functional readout is calcium entry rather than protein level. It is a small multipass membrane protein, so gentle lysis, no boiling and a membrane preparation apply, and the epitope has to be in a loop the antibody can reach in the format used.
A trpv1 antibody and a channel with a difficult reputation
TRPV1 antibodies have a long history of non specific staining, and several published patterns did not survive knockout tissue, which is why a trpv1 antibody should carry knockout validation rather than a peptide block. It is glycosylated and multipass, so the band is broad and above the calculated mass. Function is read by calcium imaging with a specific agonist, which is the control that settles it.
A piezo2 antibody and a very large mechanosensor
PIEZO2 is an unusually large multipass protein that trimerises, so a piezo2 antibody needs a low percentage gel, a long transfer and no boiling, and a missing band is a transfer problem far more often than an expression one. Because antibody specificity in this family is hard, a tagged construct or a reporter line is what most work uses to localise it.
A vgcc antibody and a complex sold under one name
A vgcc antibody names a voltage gated calcium channel subunit rather than the channel, which is assembled from a pore forming subunit and auxiliary ones, so the datasheet has to say which subunit and which family member. The pore subunit is very large and the auxiliary subunits are not, which means one blot cannot show them all well. Autoantibodies against these channels are themselves a clinical test.
Common questions
- Why does my transporter antibody show nothing on a blot?
- Most often the sample was boiled and the protein aggregated in the well, or the detergent left it in the pellet. Try thirty seven or seventy degrees and check the pellet before changing reagent.
- Why is the band a smear?
- Glycosylation. Heavily glycosylated transporters migrate broadly and above the predicted mass; enzymatic deglycosylation collapses the smear to a band and confirms the identification.
- Can I stain a transporter on intact cells?
- Only with an antibody against an extracellular loop. Most catalogue reagents for these targets are raised against intracellular regions, which is visible on the datasheet and is the commonest reason a surface stain fails.
- What control settles specificity?
- A knockout or knockdown sample. For membrane targets at native abundance the background is high enough that an isotype control proves very little, and a genetic negative is the only strong evidence.
- Why does my transporter run at an unexpected size?
- Heavy glycosylation shifts apparent mass, and heating can aggregate the protein so that it never enters the gel. Use a gentle solubilisation without boiling, enrich the membrane fraction, and validate against cells that do and do not express it.
Get a shortlist for your project
Browse by service class
Sources
Cite or embed this figure
The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.
Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/transporter-and-receptor-antibodies/.